For Heart Health Month, Amy Ahnert, MD, discussed the link between cardiovascular disease and breast cancer.

The Food and Drug Administration has approved Ozempic ® (semaglutide) to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, and cardiovascular ...